Free delivery on orders over £50

SHARE

[reviews_rating summary="no" avatar="false" icon="no" min=4 excerpt=160 more="read more" attribution="no" limit=10 view=1 excerpt=180 loop="true" interval=10]

A friendly guide to daridorexant 50mg for long-term insomniaIs. Ever lain awake at 3am, doing maths on how much sleep you’ll get if you drop off right now? If that’s become your nightly routine, you may have heard of Quviviq. So, what is Quviviq? It’s a prescription sleeping tablet that works in a very different way to older sleeping pills.

In this guide, we explain how it works, who it’s for, how fast it kicks in, side effects, safety and NHS access, all in plain English.

Five key takeaways

  • Quviviq (daridorexant) is a prescription-only tablet for adults whose insomnia has lasted at least three months and is affecting their days.
  • Instead of sedating the whole brain, it quietens orexin, the chemical that keeps you awake, so sleep can arrive more naturally.
  • The usual dose is one 50mg tablet within 30 minutes of bedtime, leaving about 9 hours before you drive.
  • It isn’t a benzodiazepine, and clinical trials found no signs of withdrawal, rebound insomnia or physical dependence.
  • NICE recommends it on the NHS when CBT for insomnia hasn’t worked or isn’t suitable, with a review within three months.
What is Quviviq courierpharmacy.co.uk

What is Quviviq?

Quviviq is the brand name for a medicine called daridorexant. It’s a prescription-only tablet made by Idorsia Pharmaceuticals, and it comes in two strengths: 25mg and 50mg. The Quviviq 50mg tablet is a light orange, rounded triangle with “50” on one side and a small “i” on the other.

It belongs to a newer family of sleep medicines called dual orexin receptor antagonists, or DORAs for short. That’s a bit of a mouthful, so we’ll unpack it shortly. Quviviq was the first medicine of its kind to be licensed in the UK, gaining approval from the medicines regulator (the MHRA) in August 2022.

What is Quviviq used for?

Quviviq is licensed for adults with insomnia that has lasted for at least three months and has a considerable impact on how they function during the day. In other words, it’s not for the odd bad night before a job interview. It’s for long-term insomnia that’s chipping away at your mood, focus and energy.

It isn’t licensed for anyone under 18, because it hasn’t been tested in children and teenagers.

What counts as long-term insomnia?

Insomnia means struggling to fall asleep, waking in the night, or waking too early and not being able to drop off again. Doctors call it long-term (or chronic) when it happens on at least three nights a week for three months or more, and it affects your daytime life.

You’re far from alone if that sounds familiar. The NICE committee that reviewed Quviviq noted that around one in five adults in England has symptoms of insomnia. Our sleep and insomnia page covers the common causes and symptoms in more detail.

How does Quviviq work?

To understand how Quviviq works, it helps to meet orexin. Orexin is a natural chemical messenger made deep in your brain. Its job is to keep you awake and alert during the day. When orexin attaches to its receptors (think of them as docking stations), your brain gets the message: stay switched on.

Here’s a handy picture. Imagine your brain is a busy nightclub and orexin is the DJ, keeping the music loud and the party going. At bedtime, the DJ is supposed to wind down. In many people with insomnia, though, the DJ keeps playing long after closing time.

Older sleeping tablets, such as benzodiazepines and Z-drugs like zopiclone, work a bit like cutting the power to the whole building. They boost a calming brain chemical called GABA, which dampens activity everywhere. It works, but you can end up groggy, wobbly and foggy the next day.

Quviviq takes a gentler approach. It simply blocks both types of orexin receptor (OX1 and OX2), so the DJ’s music can’t reach the dance floor. The wake signal fades, and sleep is allowed to happen. Studies show it does this without changing the natural balance of your sleep stages.

Why does targeting orexin matter?

Many people with long-term insomnia aren’t short of tiredness. Instead, their “awake” system is stuck in overdrive. That’s why you can feel exhausted all day, then wide awake the moment your head hits the pillow. By turning down the wake signal rather than forcing sedation, Quviviq aims to treat that overdrive more directly.

Is Quviviq a benzodiazepine?

No, Quviviq is not a benzodiazepine. Benzodiazepines (like diazepam or temazepam) and Z-drugs work on GABA receptors. Quviviq works on orexin receptors instead, so it belongs to a completely different drug class. That difference is a big part of why researchers were hopeful about its safety profile, which we’ll come to below.

Does Quviviq work? What the research shows

Yes, Quviviq works for many people with long-term insomnia, although it’s a helpful nudge rather than a knockout punch. The main evidence comes from two large clinical trials published in The Lancet Neurology in 2022. Together they included 1,854 adults across 156 sites in 17 countries, and around four in ten were aged 65 or over.

People took Quviviq or a dummy tablet (placebo) every night for three months. Researchers measured their sleep in a sleep lab and asked them to rate their sleep and daytime functioning at home.

Here’s how the Quviviq 50mg dose compared with placebo after three months:

Measure50mg compared with placebo at month 3
Time to fall asleepAbout 12 minutes faster
Time spent awake after first falling asleepAbout 18 minutes less
Total sleep (self-reported)About 20 minutes more
Daytime sleepinessSignificantly better

To put that in real terms, people on Quviviq 50mg took about an hour to fall asleep at the start of the trial. By month three, that had roughly halved to around half an hour.

An honest look at the numbers

We think it’s important to be straight with you. People taking placebo also improved, so the extra benefit from Quviviq is real but modest. The 25mg dose helped sleep too, while a 10mg dose didn’t work at all. An editorial alongside the trials pointed out that the difference on one insomnia rating scale was less than two points.

What stood out, however, was the effect on daytime life. The Quviviq 50mg group reported feeling less sleepy, more alert and in a better mood during the day. For many people, that’s the whole point.

What about longer term?

Over 800 people carried on into a 40-week extension study, giving up to 12 months of treatment in total. The improvements in sleep and daytime functioning held steady. Importantly, there were no signs that the tablet stopped working over time, and no withdrawal symptoms or rebound insomnia when people stopped.

How long does Quviviq take to work?

Each Quviviq tablet starts working quite quickly. It’s absorbed fast and reaches its peak level in your blood within one to two hours. That’s why you take it in the 30 minutes before bed, so it’s building up just as you settle down.

One thing can slow it down: a big meal. After a heavy, high-fat dinner, the tablet takes over an hour longer to reach its peak. So if you’ve just demolished a Sunday roast with all the trimmings, don’t be surprised if sleep takes its time.

Does Quviviq work the first night?

Some people notice a difference on the very first night. For others, it’s more gradual. In the trials, clear improvements were measured at one month and had grown further by three months.

Our advice is to give it a fair chance. Keep a simple sleep diary for the first few weeks, noting when you went to bed, roughly how long it took to drop off and how you felt the next day. It’s much easier to judge progress on paper than from a foggy memory at 7am. NICE recommends that treatment is reviewed within three months, and stopped if it isn’t helping enough.

Does Quviviq work immediately?

It doesn’t work like a light switch. Quviviq lowers the volume on your wake signal, but you still need the right conditions for sleep. Taking it and then scrolling through your phone for an hour is a bit like ordering a taxi home and then refusing to get in.

How to take Quviviq 50mg

The usual dose is one Quviviq 50mg tablet once a night, swallowed in the 30 minutes before you go to bed. Always follow the instructions from your prescriber and the patient leaflet, but here are the essentials:

  • Take one tablet a night by mouth, with or without food (avoiding a large meal just before).
  • Never take more than 50mg in a day, and never take a double dose.
  • Make sure you can spend a full night in bed, and leave about 9 hours before driving or using machinery.
  • If you forget your dose at bedtime, skip it. Don’t take it later in the night, or you may feel drowsy the next morning.
  • You can stop Quviviq without tapering the dose down, although it’s best to agree this with your prescriber.

Some people are prescribed the lower 25mg dose instead. This includes people with moderate liver problems and those taking certain other medicines that raise Quviviq levels in the blood.

When to take Quviviq

Take it in the evening, within half an hour of getting into bed. A practical tip from our pharmacy team: set a phone reminder for 30 minutes before your target bedtime, labelled “tablet, teeth, lights”. It sounds silly, but tying your tablet to a fixed wind-down routine makes it far easier to take it at the right time every night.

Also avoid grapefruit and grapefruit juice in the evening, as they can raise the amount of Quviviq in your blood.

Dr Ada Jex Cori taking a pill courierpharmacy.co.uk

Is Quviviq safe? Side effects and warnings

For most adults with long-term insomnia, Quviviq is considered safe when it’s prescribed after a proper assessment. In the trials, most side effects were mild to moderate, and they weren’t more common at the higher dose. Older adults had a similar side effect profile to younger adults.

Common side effects

These may affect up to 1 in 10 people:

  • headache
  • sleepiness
  • dizziness
  • feeling sick (nausea)
  • tiredness

Uncommon side effects

These may affect up to 1 in 100 people:

  • sleep paralysis
  • hallucinations while falling asleep or waking up
  • vivid dreams or nightmares
  • sleepwalking
  • allergic reactions, such as a rash or hives

Sleep paralysis deserves a quick explanation, because it can be frightening if you’re not expecting it. It’s a brief spell, usually lasting seconds to a few minutes, where you’re awake but can’t move or speak. It isn’t dangerous and it passes on its own. With Quviviq, it mainly happens in the first few weeks. If it happens to you, tell your prescriber.

Dr Ada Jex Cori side effects courierpharmacy.co.uk

Who shouldn’t take Quviviq?

You shouldn’t take Quviviq if you:

  • are allergic to daridorexant or any of the tablet’s ingredients
  • have narcolepsy (a condition that causes sudden, uncontrollable sleep)
  • take a strong CYP3A4 inhibitor medicine, such as itraconazole, clarithromycin or ritonavir

Your prescriber will take extra care if you have depression or another mental health condition, severe breathing problems such as severe COPD, liver problems, or a history of alcohol or drug misuse. Extra caution also applies if you’re over 75, pregnant or breastfeeding, as there’s less information for these groups.

Reassuringly, Quviviq didn’t worsen breathing in people with obstructive sleep apnoea or moderate COPD in studies. Even so, untreated sleep apnoea is a common hidden cause of poor sleep, so it’s always worth ruling out first.

Dr Ada Jex Cori drug warning courierpharmacy.co.uk

Driving and next-day alertness

This is one area where Quviviq has looked encouraging. In a driving simulator study, Quviviq 50mg affected driving the morning after the first dose. After four nights, no effect on driving was detected. Zopiclone, by comparison, impaired driving at both points.

The practical message is simple. Leave about 9 hours between taking your tablet and driving, and take extra care in the first few days. If you feel groggy, don’t drive, as it’s illegal to drive if a medicine impairs you.

What drugs should not be taken with Quviviq?

Quviviq is broken down mainly by a liver enzyme called CYP3A4. Think of CYP3A4 as the liver’s recycling crew. Some medicines slow that crew down, so Quviviq lingers and builds up. Others speed it up, so Quviviq is cleared before it can do its job.

Here are the main interactions to know about:

  • Strong CYP3A4 inhibitors, such as itraconazole, clarithromycin and ritonavir, must not be taken with Quviviq.
  • Moderate CYP3A4 inhibitors, such as erythromycin, ciprofloxacin, diltiazem and ciclosporin, usually mean a lower 25mg dose.
  • CYP3A4 inducers, such as efavirenz, rifampicin, carbamazepine and St John’s wort, can make Quviviq much less effective.
  • Other sedating substances, including alcohol, opioid painkillers, other sleeping tablets and sedating antihistamines, can add to drowsiness and unsteadiness.
  • Medicines with a narrow safety margin, such as digoxin, tacrolimus and high-dose simvastatin, need extra caution.
  • Grapefruit and grapefruit juice in the evening should be avoided.

There’s some good news too. The contraceptive pill, warfarin and indigestion remedies can be taken with Quviviq without dose changes, and the antidepressant citalopram showed no meaningful interaction in studies.

As a rule of thumb, always tell your prescriber and pharmacist about everything you take, including herbal remedies and anything bought over the counter.

Dr Ada Jex Cori drug interactions courierpharmacy.co.uk

Is Quviviq addictive?

The evidence so far suggests Quviviq has a low risk of addiction when taken as prescribed. In clinical trials of people with insomnia, there was no evidence of misuse, and no withdrawal symptoms when the tablets were stopped. There was no rebound insomnia either, which is when sleep becomes worse than before after stopping a sleeping pill.

That’s a welcome change from older sleeping tablets, where dependence is a well-known worry and treatment is usually limited to a few weeks.

However, “low risk” isn’t “no risk”. In a study of recreational drug users, doses two to three times higher than the maximum were rated as likeable as zolpidem. For that reason, prescribers keep a closer eye on anyone with a history of alcohol or drug misuse.

Is Quviviq a controlled substance?

In the UK, Quviviq is a prescription-only medicine. At the time of writing, it isn’t listed as a controlled drug here. In the United States, however, it’s classed as a Schedule IV controlled substance, the same category as many older sleeping tablets. So if you travel, it’s worth checking the rules at your destination before you pack it.

Is Quviviq available in the UK and on the NHS?

Yes, Quviviq is available in the UK, and it’s available on the NHS for people who meet certain criteria. In October 2023, NICE recommended daridorexant for adults whose insomnia symptoms happen on three or more nights a week for at least three months, and whose daytime functioning is considerably affected.

There’s an important condition, though. NICE says it should be used only if cognitive behavioural therapy for insomnia (CBT-I) has been tried and hasn’t worked, or if CBT-I isn’t available or suitable. Treatment should be checked within three months and stopped if it isn’t helping enough. If it continues, it should be reviewed regularly.

Does it vary by area?

Yes. Local NHS areas decide exactly how NICE guidance is put into practice. Here in Derby and Derbyshire, for example, local guidance says daridorexant shouldn’t be put on repeat prescription, should be reviewed at three months and is limited to 12 months of treatment. If you think you might qualify, your GP is the best place to start.

Where can you get Quviviq?

Quviviq is only available with a prescription. You can get it through your GP or a sleep clinic, or privately from a registered prescriber who carries out a proper clinical assessment.

Please steer clear of websites that sell sleeping tablets without a consultation. Apart from being illegal, they’re a common source of fake medicines. You can check any UK pharmacy on the General Pharmaceutical Council (GPhC) register.

How much does Quviviq cost?

On the NHS, you pay the standard prescription charge in England, and prescriptions are free in Scotland, Wales and Northern Ireland. Privately, the cost varies between providers and usually includes a consultation as well as the medicine itself. To purchase Quviviq from courierpharmacy.co.uk you will first need to complete an online consultation form.

Who is Quviviq right for?

Quviviq is best suited to adults with long-term insomnia that’s affecting their days, who have already tried CBT for insomnia or can’t access it. It isn’t a first step, and it isn’t designed for short-term sleep trouble caused by stress, jet lag or a new baby.

Why CBT-I usually comes first

CBT-I is a structured talking therapy that retrains the habits and thoughts that keep insomnia going. NICE and the NHS recommend it as the first treatment for long-term insomnia, because its benefits tend to last after the course ends.

Here’s one way to picture it. CBT-I is learning to ride the bike properly. A sleeping tablet is more like a set of stabilisers for bikes. Stabilisers can be a real help while you build confidence, but the long-term goal is to ride without them. For some people, Quviviq and CBT-I work well side by side.

Rule out the hidden culprits

Before any sleeping tablet, it’s worth checking for things that quietly wreck sleep. These include sleep apnoea (loud snoring with pauses in breathing), restless legs, low mood or anxiety, a sneaky afternoon caffeine habit, and medicines that disrupt sleep, such as some decongestants and steroids.

Who can take Quviviq courierpharmacy.co.uk

Five habits that help, with or without medication

  1. Get up at the same time every day, even at weekends. Your body clock loves routine more than a lie-in.
  2. If you’re awake for more than about 20 minutes, get up and do something calm in dim light, then go back to bed when sleepy.
  3. Set a caffeine cut-off around early afternoon. Tea, coffee, cola and energy drinks all count.
  4. Get outside in daylight within an hour of waking. Morning light helps set your internal clock.
  5. Keep a two-week sleep diary before your appointment. It turns “I sleep badly” into useful detail your prescriber can act on.

You might be wondering about melatonin too. It works differently again, and we explain how in our blog on why melatonin is prescription-only in the UK.

Frequently asked questions about Quviviq

Dr Ada Jex Cori FAQs courierpharmacy.co.uk

Who makes Quviviq?

Quviviq is made by Idorsia Pharmaceuticals, a Swiss pharmaceutical company. In the UK, it’s supplied by Idorsia Pharmaceuticals UK Ltd.

How do you say Quviviq?

Quviviq is usually pronounced “kwih-VIV-ik”. The active ingredient, daridorexant, is said “dar-ih-doh-REX-ant”. Don’t worry, your pharmacist won’t mark you down if you get it wrong.

When did Quviviq come out?

Quviviq was first approved in the United States in January 2022. The UK regulator, the MHRA, approved it in August 2022, and NICE recommended it for NHS use in October 2023.

What is Quviviq similar to?

Quviviq is most similar to suvorexant (Belsomra) and lemborexant (Dayvigo), which are also orexin receptor antagonists. Neither of those is licensed in the UK at present. Quviviq works very differently from zopiclone, zolpidem and benzodiazepines.

Does Quviviq cause weight gain?

Weight gain isn’t listed as a side effect in the official UK product information for Quviviq. If you notice changes in your appetite or weight while taking it, mention it to your prescriber or pharmacist.

Does Quviviq cause hair loss?

Hair loss isn’t a recognised side effect of Quviviq in the UK product information. Hair thinning has many common causes, including stress, thyroid problems and low iron, so it’s worth getting checked if you’re concerned.

Does Quviviq cause dementia?

There’s no evidence that Quviviq causes dementia. Some older medicines used for sleep, such as certain sedating antihistamines, have raised concerns about memory in older people, but Quviviq works in a completely different way. Researchers are still studying how sleep and brain health are linked over the long term.

Can you overdose on Quviviq?

Yes, taking too much can cause problems. In studies, healthy people given up to four times the normal dose had sleepiness, muscle weakness, poor concentration, tiredness, headache and constipation. There’s no specific antidote, so contact your doctor or NHS 111 straight away if you take too much. Call 999 if someone is very hard to wake, or has also taken alcohol or other sedating medicines.

How long does Quviviq stay in your system?

Quviviq has a half-life of about 8 hours, which means half of a dose has left your body in that time. Most of it is cleared within about two days, and it doesn’t build up with nightly use. This is why a 9-hour gap is advised before driving.

Can you take Quviviq long term?

Quviviq has been studied for up to 12 months of nightly use, with benefits that held steady and no signs of dependence. Even so, the aim is to use it for as short a time as needed. NICE recommends a review within three months, then regular check-ups if you carry on.

Disclaimer

Disclaimer: This information is for education only and isn’t a substitute for personal medical advice. Always follow your prescriber’s instructions.

References

Further reading from Courier Pharmacy

  1. Courier Pharmacy (2025a) Sleep disorders and insomnia treatments. Available at: https://courierpharmacy.co.uk/conditions/sleep/ (Accessed: 26 October 2026).
  2. Courier Pharmacy (2025b) Why is melatonin banned in the UK? Available at: https://courierpharmacy.co.uk/why-is-melatonin-banned-in-the-uk-2/ (Accessed: 26 October 2026).

Quviviq on NHS

  1. Derby and Derbyshire Integrated Care Board (2024a) Daridorexant (Quviviq): traffic light classification. Available at: https://www.derbyshiremedicinesmanagement.nhs.uk/medicines-management/full_traffic_light_classification/show_drug/daridorexant-quviviq/ (Accessed: 26 October 2026).
  2. Derby and Derbyshire Integrated Care Board (2024b) Daridorexant for treating long-term insomnia: prescribing guideline. Available at: https://derbyshiremedicinesmanagement.nhs.uk/assets/Clinical_Guidelines/Formulary_by_BNF_chapter_prescribing_guidelines/BNF_chapter_4/Insomnia_Daridorexant_prescribing_guideline.pdf (Accessed: 26 October 2026).

How Quviviq works

  1. Dutta, S., Singhal, S., Shah, R., Charan, J., Dhingra, S. and Haque, M. (2023) ‘Daridorexant as a novel pharmacotherapeutic approach in insomnia: a systematic review and meta-analysis’, Expert Opinion on Drug Safety, 22(12), pp. 1237–1251. doi: 10.1080/14740338.2023.2243217.

Quviviq product information

  1. electronic medicines compendium (emc) (2025a) QUVIVIQ 50 mg film-coated tablets: Summary of Product Characteristics. Idorsia Pharmaceuticals UK Ltd. Available at: https://www.medicines.org.uk/emc/product/15360/smpc (Accessed: 26 October 2026).
  2. electronic medicines compendium (emc) (2025b) QUVIVIQ 25 mg and 50 mg film-coated tablets: Patient Information Leaflet. Idorsia Pharmaceuticals UK Ltd. Available at: https://www.medicines.org.uk/emc/product/15360/pil (Accessed: 26 October 2026).

Safety of Quviviq

  1. Kunz, D., Dauvilliers, Y., Benes, H., Garcia-Borreguero, D., Plazzi, G., Seboek Kinter, D., Coloma, P., Rausch, M., Sassi-Sayadi, M. and Thein, S. (2023) ‘Long-term safety and tolerability of daridorexant in patients with insomnia disorder’, CNS Drugs, 37(1), pp. 93–106. doi: 10.1007/s40263-022-00980-8.
  2. Mignot, E., Mayleben, D., Fietze, I., Leger, D., Zammit, G., Bassetti, C.L.A., Pain, S., Kinter, D.S. and Roth, T. (2022) ‘Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials’, The Lancet Neurology, 21(2), pp. 125–139. doi: 10.1016/S1474-4422(21)00436-1.

Insomnia

  1. National Institute for Health and Care Excellence (2023a) Daridorexant for treating long-term insomnia. Technology appraisal guidance TA922. Available at: https://www.nice.org.uk/guidance/ta922 (Accessed: 26 October 2026).
  2. National Institute for Health and Care Excellence (2023b) Daridorexant for treating long-term insomnia: information for the public. Available at: https://nice.org.uk/guidance/ta922/resources/daridorexant-for-treating-longterm-insomnia-pdf-17094827592133 (Accessed: 26 October 2026).
  3. National Institute for Health and Care Excellence (2022) Clinical Knowledge Summaries: insomnia. Available at: https://cks.nice.org.uk/topics/insomnia/ (Accessed: 26 October 2026).
  4. NHS (n.d.) Insomnia. Available at: https://www.nhs.uk/conditions/insomnia/ (Accessed: 26 October 2026).
  5. Ziemichód, W., Grabowska, K., Kurowska, A. and Bia?a, G. (2022) ‘A comprehensive review of daridorexant, a dual-orexin receptor antagonist as new approach for the treatment of insomnia’, Molecules, 27(18), 6041. doi: 10.3390/molecules27186041.

Courierpharmacy.co.uk divider Dr Ada Jex Cori

Error getting reviews. Possible timeout.

{"47351":47351,"42749":42749,"42605":42605,"42603":42603,"42600":42600,"42593":42593,"42583":42583,"42567":42567,"42547":42547,"40672":40672,"40495":40495,"40227":40227,"40156":40156,"37533":37533,"37525":37525,"37518":37518,"37510":37510,"37499":37499,"37025":37025,"36969":36969,"36383":36383,"35982":35982,"35862":35862,"35865":35865,"35688":35688,"35611":35611,"35477":35477,"35417":35417,"35106":35106}